Scientists search for a new tool to track a rare neurological disease
NCT ID NCT06496451
Summary
This study aimed to find a new way to measure a specific biological signal (frataxin mRNA) in the blood and spinal fluid of people with Friedreich's ataxia. Researchers tested 10 adult patients to see if this measurement could serve as a useful tool to track the disease and monitor future treatments. The goal was to develop a better method for researchers to see if new therapies are working to increase frataxin levels in the brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.